e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of O
2
on exercise capacity (6-minute-walking-distance, 6MWD) in COPD
I. Heinzelmann, A. Jerrentrup, C. Vogelmeier, K. Kenn (Schoenau am Koenigssee, Marburg, Germany)
Source:
Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Session:
Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Session type:
Poster Discussion
Number:
2996
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Heinzelmann, A. Jerrentrup, C. Vogelmeier, K. Kenn (Schoenau am Koenigssee, Marburg, Germany). The influence of O
2
on exercise capacity (6-minute-walking-distance, 6MWD) in COPD. Eur Respir J 2011; 38: Suppl. 55, 2996
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015
The effect of non-invasive ventilation (NIV) during exercise on inspiratory capacity (IC) and endurance time (Tlim) in patients with severe COPD
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019
Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Reduced submaximal exercise performance in COPD patients at moderate altitude (2590m)
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014
Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007
Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008
Relationships between changes in the respiratory distress level of COPD patients undergoing a six-minute walking distance test, their physical functions, and exercise capacity
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Is a double 6-minute walk test (6MWT) required as part of the routine assessment of pulmonary rehabilitation (PR) in COPD patients?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Why do COPD patients improve six minute walking distance (6MWD) with the use of a rollator?
Source: Eur Respir J 2003; 22: Suppl. 45, 330s
Year: 2003
Effects of exercise training on quality of life and 6 minute walk distance (6MWD) in adults with fixed airway obstruction asthma (FAOA)
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008
Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Determinants of cardio-pulmonary exercise test (CPET) and shuttle walking test (SWT) in COPD patients are different
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Influence of changes in physical activity (PA) and exercise capacity on mortality and quality of life (QL) in COPD
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients?
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012
Can diagnostic staff (DS) or patients predict whether the 6-minute walk distance (6MWD) will improve to a relevant extent at a repeated 6-minute walk test (R-6MWT)?
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Analysis of oxygen saturation (O2 sat.) During the six minutes walk distance (6MWD) test in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Relationship between IL-6 and FEV
1
interaction and six minute walk distance (6MWD) performance in COPD patients
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008
The impact of Symkevi (Tezacaftor/Ivacaftor) on exercise capacity in adolescents with CF
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
Influence of hospitalizations because of COPD exacerbation in the six-minute walk test (6MWT)
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
6-minute walk test (6MWT) and Sit-to-Stand Test (STST) as outcome parameters in pulmonary rehabilitation (PR) of COPD patients
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept